Umedica Laboratories Profile
Key Indicators
- Authorised Capital ₹ 17.50 Cr
as on 28-10-2024
- Paid Up Capital ₹ 3.11 Cr
as on 28-10-2024
- Company Age 43 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 584.34 Cr
as on 28-10-2024
- Satisfied Charges ₹ 136.33 Cr
as on 28-10-2024
About Umedica Laboratories
The Corporate was formerly known as Umedica Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 17.50 Cr and a paid-up capital of Rs 3.11 Cr.
The company currently has active open charges totaling ₹584.34 Cr. The company has closed loans amounting to ₹136.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Doshi, Vandana Doshi, and Rupesh Kamdar serve as directors at the Company.
- CIN/LLPIN
U24231GJ1982PTC141202
- Company No.
224236
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1982
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Umedica Laboratories Private Limited offer?
Umedica Laboratories Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Inspection & Quality Check Services, Quality Inspection Service, Content Writing Service, Research Development Services.
Who are the key members and board of directors at Umedica Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Doshi  | Director | 05-Jan-1982 | Current |
| Vandana Doshi | Director | 17-Mar-2017 | Current |
| Rupesh Kamdar | Director | 02-Aug-2018 | Current |
Financial Performance of Umedica Laboratories.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Umedica Laboratories?
Unlock access to Umedica Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Amoli Investment Services Private LimitedActive 15 years 8 monthsManish Doshi and Vandana Doshi are mutual person
- Amoli Properties Private LimitedActive 15 years 8 months
Manish Doshi and Vandana Doshi are mutual person
- Umedica Properties Private LimitedActive 15 years 8 months
Manish Doshi and Vandana Doshi are mutual person
Ainos Pharmaceuticals Private LimitedActive 1 year 3 monthsManish Doshi and Vandana Doshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jun 2022 | ₹15.00 Cr | Open |
State Bank Of India Creation Date: 10 Feb 2022 | ₹30.00 Cr | Open |
Sbicap Trustee Company Limited Creation Date: 01 Nov 2021 | ₹77.89 Cr | Open |
How Many Employees Work at Umedica Laboratories?
Unlock and access historical data on people associated with Umedica Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Umedica Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umedica Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
